Your browser doesn't support javascript.
The Adoption of Viral Capsid-Derived Virus-Like Particles (VLPs) for Disease Prevention and Treatments.
Bogani, Giorgio; Raspagliesi, Francesco; Ditto, Antonino; de la Fuente, José.
  • Bogani G; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.
  • Raspagliesi F; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.
  • Ditto A; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy.
  • de la Fuente J; SaBio. Instituto de Investigación en Recursos Cinegéticos, IREC (CSIC,UCLM,JCCM) Ronda de Toledo s/n, 13005 Ciudad Real, Spain.
Vaccines (Basel) ; 8(3)2020 Aug 02.
Article in English | MEDLINE | ID: covidwho-714559
ABSTRACT
In the present paper, Mohosen et al. [1] reviewed the evidence of the interaction between virus-like particles (VLPs) and the innate immune system. [...].
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: Vaccines8030432

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2020 Document Type: Article Affiliation country: Vaccines8030432